Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α

BACKGROUND: Zinc-α2-glycoprotein 1 (AZGP1) plays important roles in metabolism-related diseases. The underlying molecular mechanisms and therapeutic effects of AZGP1 remain unknown in non-alcoholic fatty liver disease (NAFLD). AIM: To explore the effects and potential mechanism of AZGP1 on NAFLD in...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:World J Gastroenterol
Hoofdauteurs: Liu, Ting, Luo, Xin, Li, Zheng-Hong, Wu, Jun-Cheng, Luo, Sheng-Zheng, Xu, Ming-Yi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Baishideng Publishing Group Inc 2019
Onderwerpen:
Basic Study
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6767980/
https://ncbi.nlm.nih.gov/pubmed/31576092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i36.5451
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items